Guido Dallmann

Learn More
BACKGROUND Metabolomic processes have been identified as being strongly linked to the development of Alzheimer's disease (AD). Thus, lipid metabolites appear to be highly useful as diagnostic substrates for the diagnosis of AD and mild cognitive impairment (MCI) in plasma. METHODS We analyzed plasma samples from controls (n = 35), MCI (n = 33), and AD(More)
  • 1